Evidence map›Paper›PMID 41561106›Full record

ArticleERJ open research2026

Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Marissa O'Callaghan, Sarah H Forde, Alessandro N Franciosi, Maitreyi Penugonda, Remi Diesler, Helen O'Brien, Wieneke Buikhuisen, Hussein Almeamar, Bilal F Samhouri, Jay H Ryu and 32 more

Abstract read
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Marissa O'CallaghanDepartment of Respiratory Medicine, St Vincent's University Hospital, Dublin, Ireland.
Sarah H FordeSchool of Medicine, University College Dublin, Dublin, Ireland.
Alessandro N FranciosiDepartment of Respiratory Medicine, St Vincent's University Hospital, Dublin, Ireland.ORCID https://orcid.org/0000-0002-4241-8718
Maitreyi PenugondaDepartment of Respiratory Medicine, St Vincent's University Hospital, Dublin, Ireland.
Remi DieslerNational Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, UMR754, INRAE, ERN-LUNG, Lyon, France.ORCID https://orcid.org/0000-0003-0746-357X
Helen O'BrienDepartment of Respiratory Medicine, St Vincent's University Hospital, Dublin, Ireland.
Wieneke BuikhuisenDepartment of Thorax Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Hussein AlmeamarNational Neuroendocrine Tumour Clinic, St Vincent's University Hospital, Dublin, Ireland.
Bilal F SamhouriDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Jay H RyuDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Marcel VeltkampILD Center of Excellence, Member of European Reference Network-Lung, St Antonius Hospital, Nieuwegein, Netherlands.
Effrosyni D ManaliDepartment of Pulmonary Medicine, General University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Aggeliki LazaratouDepartment of Pulmonary Medicine, General University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Spyros A PapirisDepartment of Pulmonary Medicine, General University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Francesco BonellaCenter for Interstitial and Rare Lung Diseases, Ruhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany.ORCID https://orcid.org/0000-0001-7579-9767
Laurie CarrDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Vincent CottinNational Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, UMR754, INRAE, ERN-LUNG, Lyon, France.ORCID https://orcid.org/0000-0002-5591-0955
Camille TailleDepartment of Pulmonology and Lung Transplantation, Bichat Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité University, Paris, France.ORCID https://orcid.org/0000-0001-9768-5728
Francis X McCormackDepartment of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.ORCID https://orcid.org/0000-0001-7168-9464
Nishant GuptaDepartment of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.ORCID https://orcid.org/0000-0001-9112-1315
Jonathan StrosbergDepartment of Gastrointestinal Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Fillipo M LococoDepartment of Thoracic Surgery, Universita Cattolica del Sacro Cuore, Rome, Italy.
Sergio HarariDivision of Pulmonary and Respiratory Intermediate Care Unit, MultiMedica IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0001-8629-7391
Giuseppe PelosiDepartment of Oncology and Hemato-Oncology, University of Milan.
Riccardo PapaInter-Hospital Pathology Division, IRCCS MultiMedica Group, Milan, Italy.
Demosthenes BourosNational and Kapodistrian University of Athens, Athens, Greece.ORCID https://orcid.org/0000-0002-0685-0765
Lykourgos Kolilekas7th Pulmonary Department, Athens Chest Hospital "Sotiria", Athens, Greece.
Zoe DaniilDepartment of Respiratory Medicine, University of Thessaly, University General Hospital of Larissa, Larissa, Greece.
Ilias DimeasDepartment of Respiratory Medicine, University of Thessaly, University General Hospital of Larissa, Larissa, Greece.ORCID https://orcid.org/0000-0001-6933-1068
Fernanda Hernandez-GonzalezDepartment of Respiratory Medicine, Hospital Clínic de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5113-4285
Jacobo SellaresDepartment of Respiratory Medicine, Hospital Clínic de Barcelona, Barcelona, Spain.
Paolo SpagnoloRespiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy.
Rachel K CrowleyNational Neuroendocrine Tumour Clinic, St Vincent's University Hospital, Dublin, Ireland.
Dermot O' TooleNational Neuroendocrine Tumour Clinic, St Vincent's University Hospital, Dublin, Ireland.
Donal O'SheaNational Neuroendocrine Tumour Clinic, St Vincent's University Hospital, Dublin, Ireland.
Sean QuinnDepartment of Radiology, St Vincent's University Hospital, Dublin, Ireland.
David J MurphyDepartment of Radiology, St Vincent's University Hospital, Dublin, Ireland.
Aurelie FabreDepartment of Pathology, St Vincent's University Hospital, Dublin, Ireland.ORCID https://orcid.org/0000-0001-8176-1386
Adam J ByrneSchool of Medicine, University College Dublin, Dublin, Ireland.
Michael P KeaneDepartment of Respiratory Medicine, St Vincent's University Hospital, Dublin, Ireland.ORCID https://orcid.org/0000-0003-4507-0742
Ludovic FournelDepartment of Thoracic Surgery, Centre Université de Paris Cité, Cochin, Paris, France.
Cormac McCarthyDepartment of Respiratory Medicine, St Vincent's University Hospital, Dublin, Ireland.ORCID https://orcid.org/0000-0003-2896-5210

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is characterised by diffuse bronchial hyperplasia of pulmonary neuroendocrine cells, which are situated within the walls of bronchi and bronchioles. Presenting symptoms are nonspecific and the clinical course varies, making diagnosis challenging. We sought to describe the clinical characteristics of patients with DIPNECH in a large multinational case series to guide and inform future care and research. Methods: Data were collated from 18 international centres. Information collected included disease presentation, pulmonary function testing, histopathology, radiological patterns and outcomes. The relationship between clinical features, radiology and symptoms were explored in parametric and nonparametric group-wise analyses, univariate linear regressions, and multivariate binomial logistic regression. Results: The mean±sd age of the 258 patients in this study was 63.3±10.6 years and 93.4% were female. Diffuse pulmonary nodules (98.8%) and mosaic attenuation (59.1%) were the most common radiological findings and 29.5% had obstructive spirometry with a mean±sdforced expiratory volume in 1 s (FEV Conclusions: The presence of radiological bronchial wall thickening is associated with the presence of symptoms, while mosaic attenuation is correlated with airflow obstruction; hence, the presence of these radiological findings has the potential to guide possible treatment decisions.

Identifiers

PMID41561106
PMCPMC12813684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.